ITRM — Iterum Therapeutics plc
$0.0300-57.39%
Last close: · regular session
Last 36 sessions
Opening the full analysis uses 1 of your 3 free tickers today.
Chart, dilution, float and news for ITRM in the TickerWise workspace.
Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company was incorporated in 2015 and is headquartered in Dublin, Ireland.
Company profile
- Sector: Healthcare
- Industry: Biotechnology
- Country: IE
- Exchange: NASDAQ
- Employees: 9
- Website: https://www.iterumtx.com
Latest SEC filings for ITRM
Opening the full analysis uses 1 of your 3 free tickers today.
Educational tool only — not investment advice.